Skip to main content
. 2009 Mar 10;296(5):E1164–E1171. doi: 10.1152/ajpendo.00054.2009

Table 3.

Fasting blood glucose, insulin, HOMA-IR, and glucose AUC


6-Wk Intervention
12-Wk Intervention
HFSED HFEX LFSED LFEX HFSED HFEX LFSED LFEX
n 5 7 5 6 12 13 14 14
Glucose, mmol/l 13.27±0.6a 10.51±0.30b 11.50±0.66a,b 11.43±0.85a,b 12.87±0.43a 10.88±0.29b,c 11.75±0.45a,b 9.52±0.34c*
Insulin, μIU/ml 15.95±1.8a 10.23±0.4b 10.78±1.1b 7.90±0.7b 24.52±4.7a 20.91±3.4a,b 13.96±1.1a,b* 12.61±1.3b*
HOMA-IR 9.41±1.2a 4.77±0.2b 5.39±0.6b 4.07±0.5b 14.08±2.8a 10.15±1.7a,b* 7.34±0.7b 5.4±0.6b
Glucose AUC 49,563±800a 42,210±2,243a,b 35,019±2,235b,c 30,555±2,805c 47,182±1,925a 46,648±2,608a 37,733±1,941b 35,418±2,439b

Values are means ± SE. HOMA-IR, homeostatic model of insulin resistance; AUC, area under the curve. All variables except glucose AUC were measured in the fasted state (12 h of no food). Different letters represent significant between-group differences within time point based on ANOVA with post hoc Tukey's test.

*

Significant duration effect within group.